(SHEL) Shell - Ratings and Ratios
Oil, Gas, LNG, Chemicals, Fuels
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.04% |
| Yield on Cost 5y | 8.65% |
| Yield CAGR 5y | 14.96% |
| Payout Consistency | 94.2% |
| Payout Ratio | 52.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 19.4% |
| Value at Risk 5%th | 32.7% |
| Relative Tail Risk | 2.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | -1.66 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.296 |
| Beta | 0.622 |
| Beta Downside | 0.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.47% |
| Mean DD | 4.32% |
| Median DD | 3.29% |
Description: SHEL Shell December 01, 2025
Shell plc (NYSE:SHEL) is a globally integrated energy and petrochemical company operating across six segments: Integrated Gas, Upstream, Marketing, Chemicals & Products, and Renewables & Energy Solutions. Its core activities include upstream exploration and production of crude oil, natural gas, and LNG; midstream transport; downstream marketing of fuels, lubricants, and chemicals; and a growing portfolio in renewables, hydrogen, carbon capture, and electric-vehicle services.
Key recent metrics highlight the company’s scale and transition focus: 2023 adjusted net profit was $20.1 billion, free cash flow reached $7 billion, and upstream production averaged 3.4 million barrels of oil equivalent per day. Capital allocation in 2023-24 targets $30 billion in capex, with roughly 15% earmarked for low-carbon projects such as wind, solar, and hydrogen, reflecting sector-wide pressure from decarbonisation mandates and rising LNG demand in Asia.
For a deeper, data-driven look at Shell’s valuation sensitivities, the ValueRay platform provides a transparent model that can help you assess the impact of these drivers.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (14.60b TTM) > 0 and > 6% of Revenue (6% = 16.12b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.75% (prev 12.11%; Δ -0.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 46.15b > Net Income 14.60b (YES >=105%, WARN >=100%) |
| Net Debt (40.92b) to EBITDA (53.98b) ratio: 0.76 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.95b) change vs 12m ago -7.58% (target <= -2.0% for YES) |
| Gross Margin 15.11% (prev 16.31%; Δ -1.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 69.54% (prev 75.14%; Δ -5.60pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.68 (EBITDA TTM 53.98b / Interest Expense TTM 4.76b) >= 6 (WARN >= 3) |
Altman Z'' 3.69
| (A) 0.08 = (Total Current Assets 121.18b - Total Current Liabilities 89.62b) / Total Assets 377.74b |
| (B) 0.51 = Retained Earnings (Balance) 192.46b / Total Assets 377.74b |
| (C) 0.08 = EBIT TTM 31.77b / Avg Total Assets 386.34b |
| (D) 0.88 = Book Value of Equity 176.11b / Total Liabilities 199.91b |
| Total Rating: 3.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.15
| 1. Piotroski 5.0pt |
| 2. FCF Yield 10.36% |
| 3. FCF Margin 9.65% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda 0.76 |
| 6. ROIC - WACC (= 5.03)% |
| 7. RoE 8.18% |
| 8. Rev. Trend -85.33% |
| 9. EPS Trend -66.25% |
What is the price of SHEL shares?
Over the past week, the price has changed by -6.11%, over one month by -2.37%, over three months by -2.75% and over the past year by +13.61%.
Is SHEL a buy, sell or hold?
- Strong Buy: 9
- Buy: 6
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SHEL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 83 | 17.2% |
| Analysts Target Price | 83 | 17.2% |
| ValueRay Target Price | 81.4 | 15% |
SHEL Fundamental Data Overview January 03, 2026
P/E Forward = 11.1732
P/S = 0.778
P/B = 1.1895
P/EG = 1.6843
Beta = -0.094
Revenue TTM = 268.66b USD
EBIT TTM = 31.77b USD
EBITDA TTM = 53.98b USD
Long Term Debt = 41.46b USD (from longTermDebt, last fiscal year)
Short Term Debt = 10.02b USD (from shortTermDebt, last quarter)
Debt = 73.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.92b USD (from netDebt column, last quarter)
Enterprise Value = 250.27b USD (209.34b + Debt 73.98b - CCE 33.05b)
Interest Coverage Ratio = 6.68 (Ebit TTM 31.77b / Interest Expense TTM 4.76b)
EV/FCF = 9.65x (Enterprise Value 250.27b / FCF TTM 25.94b)
FCF Yield = 10.36% (FCF TTM 25.94b / Enterprise Value 250.27b)
FCF Margin = 9.65% (FCF TTM 25.94b / Revenue TTM 268.66b)
Net Margin = 5.43% (Net Income TTM 14.60b / Revenue TTM 268.66b)
Gross Margin = 15.11% ((Revenue TTM 268.66b - Cost of Revenue TTM 228.06b) / Revenue TTM)
Gross Margin QoQ = 16.73% (prev 14.87%)
Tobins Q-Ratio = 0.66 (Enterprise Value 250.27b / Total Assets 377.74b)
Interest Expense / Debt = 1.73% (Interest Expense 1.28b / Debt 73.98b)
Taxrate = 31.60% (2.49b / 7.88b)
NOPAT = 21.73b (EBIT 31.77b * (1 - 31.60%))
Current Ratio = 1.35 (Total Current Assets 121.18b / Total Current Liabilities 89.62b)
Debt / Equity = 0.42 (Debt 73.98b / totalStockholderEquity, last quarter 175.82b)
Debt / EBITDA = 0.76 (Net Debt 40.92b / EBITDA 53.98b)
Debt / FCF = 1.58 (Net Debt 40.92b / FCF TTM 25.94b)
Total Stockholder Equity = 178.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.78% (Net Income 14.60b / Total Assets 377.74b)
RoE = 8.18% (Net Income TTM 14.60b / Total Stockholder Equity 178.52b)
RoCE = 14.44% (EBIT 31.77b / Capital Employed (Equity 178.52b + L.T.Debt 41.46b))
RoIC = 11.40% (NOPAT 21.73b / Invested Capital 190.61b)
WACC = 6.37% (E(209.34b)/V(283.32b) * Re(8.21%) + D(73.98b)/V(283.32b) * Rd(1.73%) * (1-Tc(0.32)))
Discount Rate = 8.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.63%
[DCF Debug] Terminal Value 83.86% ; FCFF base≈29.17b ; Y1≈27.87b ; Y5≈26.95b
Fair Price DCF = 231.1 (EV 698.66b - Net Debt 40.92b = Equity 657.73b / Shares 2.85b; r=6.37% [WACC]; 5y FCF grow -5.85% → 2.90% )
EPS Correlation: -66.25 | EPS CAGR: -49.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: -85.33 | Revenue CAGR: -5.95% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.51 | Chg30d=+0.057 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=6.60 | Chg30d=-0.113 | Revisions Net=-1 | Growth EPS=+0.6% | Growth Revenue=-0.2%
Additional Sources for SHEL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle